The novel approach of tirzepatide peptide represents a significant development in the care of diabetes mellitus type 2. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide783874.ltfblog.com/40410276/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment